December 3, 2013 at 7:35 PM
3 out of 4 Americans living with HIV don’t have their infection under control
Regarding your recent article, what a wonderful boon for humanity [“Obama reveals $100 million HIV research initiative,” News, Dec. 3].
And kudos for his pledge to support The Global Fund to Fight AIDS, Tuberculosis and Malaria as long as the other countries do their part.
People don’t realize that the U.S. spends only a quarter of 1 percent of our total federal budget on global health.
Science has discovered that getting treatment to an HIV-infected person early enough can reduce the risk of infecting others by 96 percent. Science magazine named the AIDS treatment-as-prevention strategy as its 2001 “breakthough of the year.”
But the Centers for Disease Control and Prevention has stated that about 3 out of 4 Americans living with HIV do not have their infections under control. Extremely drug-resistant TB has now emerged and has been documented in at least 77 countries, including our own.
Thank you, President Obama.
— Donna Schindler Munro, Bremerton
December 2, 2013 at 7:04 PM
Patients should be allowed admission to the center with the greatest expertise
After reading the article in Sunday’s paper about the insurance networks, it seems to me that there is an assumption on the part of everybody that one size fits all when it comes to hospital caregivers ["Policies’ limits shock shopper,” page one, Dec. 1].
This is simply not the case. During the 25 years I worked in one of the major Seattle hospitals, my area of expertise involved urology, nephrology, diabetes and organ transplantation. I had no experience in caring for burn patients, patients with severe trauma or patients undergoing chemotherapy.
Physicians depend on nurses to detect subtle changes in a patient’s condition and to report those changes back to the physician. Whether a patient lives or dies can depend on these observations. A nurse who has no experience with that patient’s particular problem is less likely to detect these changes.
October 29, 2013 at 7:33 PM
Young women should be aware of the risk of prescribed medication
An Oct. 24 Seattle Times article reported that the number of stroke victims has increased 25 percent during the past two decades with the increase in the U.S. occurring among the young and middle-aged [“Study: Strokes up among young,” News, Oct. 24].
The article failed to mention a plausible explanation of this increase of blood clots and strokes among young women — the widespread use of combined hormonal contraceptives, CHC’s. Recently marketed contraceptives containing drospirenone/ethinyl estradiol, such as YAZ, Zarah, Loryna and Gianvi, which promise to treat acne and symptoms of premenstrual disorder as well as provide contraception, have been especially popular with young women. Unfortunately they also carry with them a higher risk of blood clots and stroke.
According to the final report of the FDA on Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease, issued on Oct. 27, 2011, “There has long been concern about the risk of both arterial and venous cardiovascular complications imparted by the use of combined hormonal contraceptives (CHCs) in large part because of the prothrombotic effects of estrogen.
The FDA report found that the newer CHC’s, including pills containing drospirenone, the etonogestrel/estradiol vaginal ring, and the norelgestromin/ethinyl estradiol transdermal patch were all associated with an even greater risk of thromboembolism.
The fact that these CHC’s are prescribed to women as young as 10 to 14 years of age, who lack the sophistication to judge their risk, may explain the growing number of strokes among the very young.
Deborah Ummel, Bellevue
Trending with readers